GSK Rejects £50bn Bid For Consumer Healthcare From Unilever

 
• By Tom Gallen

GSK says London-based Unilever's £50bn bid for Consumer Healthcare fundamentally undervalues a business which generated sales close to £10bn last year and is expected to grow 4-6% over the medium term. The rejection has not dissuaded Unilever, however, with the company intent on stepping up its presence in the health, beauty and hygiene categories.

• Source: Shutterstock

GlaxoSmithKline plc has rejected three unsolicited bids for its Consumer Healthcare unit from Unilever PLC on the grounds that the offers “fundamentally undervalued” the business.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

More from Business